News

Dewpoint
|
May 24, 2022
|
Category:

Assaying Small Molecule Partitioning into Biomolecular Condensates

Poster presented at KEYSTONE SYMPOSIA on Modern Phenotypic Drug Discovery: from Chemical Biology to Therapeutics

> Download the PDF file

Media Contact

media@dewpointx.com

Investor Contact

Scott Peterson, Ph.D.
SVP, Corporate Development and Investor Relations
Dewpoint Therapeutics
speterson@dewpointx.com
Dewpoint Therapeutics
451 D Street, Suite 104
Boston, MA 02210
USA
© 2019-2023 - Dewpoint Therapeutics

Design: SALIENCE Communication / Publiepress
Scientific animation: Visual Science